Glycated Haemogloin, Fasting Plasma Glucose, Plasminogen Activator Inhibitor Type-1, and Soluble Thrombomodulin Levels in Patients with Type 2 Diabetes Mellitus. NJPS [Internet]. 31. Dezember 2021 [zitiert 6. April 2026];36(2):159-64. Verfügbar unter: https://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/1520